Our History

Before Thanksgiving break in 2004, as postdoctoral fellows at Duke University, Derek Jantz, Ph.D. and Jeff Smith, Ph.D. were excited about a new discovery – one that would lead to the foundation of the proprietary ARCUS genome editing technology. Teaming up with a then-Duke Fuqua School of Business student, Matt Kane, the three of them spun the fledgling technology out of Duke to form Precision BioSciences in March 2006. Some of the first ARCUS editing successes were in corn, soybeans, cotton, and other crop plants. That heritage of excellence lives and thrives today as our wholly owned subsidiary, Elo Life Systems.

At the time, gene editing as a clinical intervention to treat – let alone cure – diseases was practically science fiction. But rapid advances and breakthroughs mean that moving from cell culture to the clinic is now an exciting reality – and Precision has quietly built what is arguably the leading gene editing platform paving the way for the next frontier of therapeutic cell and gene editing therapies.

Mission and Values

Our team is built on a foundation of innovation and scientific discovery, and all employees at the company, whom we passionately refer to as Precisioneers, share in our mission – Dedicated to Improving Life – and our values:

  • We persevere and never give up.
  • We are never satisfied with the status quo and are constantly searching for innovation.
  • We respect one and other and are always seeking collaboration.
  • We adapt and are ready and willing to change.
  • We hold ourselves accountable and always deliver on our commitments.